Delayed Anemia after Treatment with Injectable Artesunate in the Democratic Republic of the Congo: A Manageable Issue

Delayed Anemia after Treatment with Injectable Artesunate in the Democratic Republic of the Congo: A Manageable Issue

Cases of delayed hemolytic anemia have been described after treatment with injectable artesunate, the current World Health Organization (WHO)–recommended first-line drug for the treatment of severe malaria. A total of 350 patients (215 [61.4%] < 5 years of age and 135 [38.6%] ≥ 5 years of age) we...

Full description

Bibliographic Details
Main Authors: Burri, Christian, Ferrari, Giovanfrancesco, Ntuku, Henry Maggi, Kitoto, Antoinette Tshefu, Duparc, Stephan, Hugo, Pierre, Mitembo, Didier Kalemwa, Lengeler, Christian
Format: Online
Language:English
Published: The American Society of Tropical Medicine and Hygiene 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4183412/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4183412/

Similar Items